Leading the way to safer medication
 Crosscheck  Recommender

Aclidinium bromide

Description

Aclidinium bromide is a competitive, selective muscarinic receptor antagonist (also known as an anticholinergic), with a longer residence time at the M3 receptors than the M2 receptors. M3 receptors mediate contraction of airway smooth muscle. Inhaled aclidinium bromide acts locally in the lungs to antagonise M3 receptors of airway smooth muscle and induce bronchodilation.

ATC Classification

Code
Title
Category
R03BB05
Aclidinium bromide
R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BB Anticholinergics

Trade names

Trade name
Countries

Australia Austria Netherlands

Austria Cyprus Netherlands Singapore

United States

Trade names (in combination): BRIMICA DUAKLIR

Product Monographs

Monograph
Type
Country
BRETARIS GENUAIR Inhalation powder
MPI, EU: SmPC